Valerie Fauvelle

Valerie Fauvelle is the Senior Vice President of Regulatory & Quality at Jade Biosciences. She brings nearly 25 years of experience in the biotech and pharma industries where she developed expertise in regulatory submissions, compliance frameworks, and quality oversight. Prior to joining Jade, she held leadership roles at several companies, including Chinook Therapeutics, where she guided regulatory strategy through clinical development and early commercialization as the SVP of Regulatory Affairs, interim head of Quality, head of Medical Writing and the Program Team Leader (PTL) for an early clinical asset.

Her career spans senior regulatory positions at Rainier Therapeutics, Cascadian Therapeutics (acquired by Seagen), Oncothyreon, Gilead Sciences, and ICOS Corporation, She began her career at Seattle Genetics and gained early healthcare experience as a Medical Technician at Phoenix Central Laboratory.

Ms. Fauvelle holds an M.S. in Clinical Research Administration from The George Washington University and a B.A. from the University of Washington.